BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,163,497 | -20.6% | 23,168 | -0.1% | 0.15% | -27.2% |
| Q2 2023 | $1,465,861 | +40.5% | 23,194 | +0.0% | 0.20% | +43.3% |
| Q1 2023 | $1,043,093 | -18.2% | 23,185 | -20.4% | 0.14% | -31.9% |
| Q4 2022 | $1,275,660 | +7.8% | 29,118 | +62.2% | 0.21% | +15.6% |
| Q3 2022 | $1,183,000 | +378.9% | 17,948 | +363.3% | 0.18% | +752.4% |
| Q1 2022 | $247,000 | -94.5% | 3,874 | -91.6% | 0.02% | -93.5% |
| Q1 2021 | $4,473,000 | -27.4% | 46,000 | -16.2% | 0.32% | -22.8% |
| Q4 2020 | $6,159,000 | +3.0% | 54,918 | -14.9% | 0.42% | +5.3% |
| Q3 2020 | $5,979,000 | +11.1% | 64,500 | -6.6% | 0.40% | +7.9% |
| Q2 2020 | $5,384,000 | -3.7% | 69,031 | -27.8% | 0.37% | -17.4% |
| Q1 2020 | $5,592,000 | +14.4% | 95,627 | +56.8% | 0.44% | +47.2% |
| Q4 2019 | $4,887,000 | +15.3% | 61,000 | +5.7% | 0.30% | +19.4% |
| Q3 2019 | $4,239,000 | -22.1% | 57,700 | +0.1% | 0.25% | -21.5% |
| Q2 2019 | $5,439,000 | – | 57,660 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |